Pulmonary Embolism as an Adverse Drug Event of Intravenous Immunoglobulin Therapy, Katasha S. Butler, Deborah S. Zeitlin
Deborah Zeitlin

Pulmonary Embolism as an Adverse Drug Event of Intravenous Immunoglobulin Therapy, Katasha S. Butler, Deborah S. Zeitlin
Deborah Zeitlin

Pulmonary Embolism as an Adverse Drug Event of Intravenous Immunoglobulin Therapy, Katasha S. Butler, Deborah S. Zeitlin
Scholarship and Professional Work – COPHS